124 related articles for article (PubMed ID: 2534001)
1. The serial hemostasis-related changes in patients with cerebral infarction: comparison between progressing and non-progressing stroke.
Ho CH; Hu HH; Wong WJ
Thromb Res; 1989 Dec; 56(5):635-47. PubMed ID: 2534001
[TBL] [Abstract][Full Text] [Related]
2. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
3. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
Nakajima H
Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
[TBL] [Abstract][Full Text] [Related]
4. Serial thrombolysis-related changes after thrombolytic therapy with TPA in patients with acute myocardial infarction.
Ho CH; Wang SP
Thromb Res; 1990 May; 58(3):331-41. PubMed ID: 1693793
[TBL] [Abstract][Full Text] [Related]
5. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
Rosove MH; Frank HJ; Harwig SS
Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
[TBL] [Abstract][Full Text] [Related]
6. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction.
Tombul T; Atbas C; Anlar O
J Clin Neurosci; 2005 May; 12(4):429-34. PubMed ID: 15925775
[TBL] [Abstract][Full Text] [Related]
8. Changes in hemostasis activity during delivery and the immediate postpartum period.
Gerbasi FR; Bottoms S; Farag A; Mammen EF
Am J Obstet Gynecol; 1990 May; 162(5):1158-63. PubMed ID: 2140236
[TBL] [Abstract][Full Text] [Related]
9. Haemostatic variables in patients with unstable angina.
al-Nozha M; Gader AM; al-Momen AK; Noah MS; Jawaid M; Arafa M
Int J Cardiol; 1994 Mar; 43(3):269-77. PubMed ID: 8181885
[TBL] [Abstract][Full Text] [Related]
10. Platelet activation and fibrinopeptide formation in pulmonary hypertension.
Schulman LL; Grossman BA; Owen J
Chest; 1993 Dec; 104(6):1690-3. PubMed ID: 8252943
[TBL] [Abstract][Full Text] [Related]
11. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
[TBL] [Abstract][Full Text] [Related]
12. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
[TBL] [Abstract][Full Text] [Related]
13. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation after long distance running: antithrombin III prevents fibrin formation.
Bärtsch P; Haeberli A; Straub PW
Thromb Haemost; 1990 Jun; 63(3):430-4. PubMed ID: 2402746
[TBL] [Abstract][Full Text] [Related]
15. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
16. Activation of thrombosis and fibrinolysis following brain infarction.
Kataoka S; Hirose G; Hori A; Shirakawa T; Saigan T
J Neurol Sci; 2000 Dec; 181(1-2):82-8. PubMed ID: 11099716
[TBL] [Abstract][Full Text] [Related]
17. Alterations of haemostatic markers in various subtypes and phases of stroke.
Yamazaki M; Uchiyama S; Maruyama S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
[TBL] [Abstract][Full Text] [Related]
18. [Relation between blood coagulability and prognosis in patients with ovarian cancer].
Sawaguchi K; Narumiya H; Yabushita H; Noguchi M; Nakanishi M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):313-9. PubMed ID: 2358716
[TBL] [Abstract][Full Text] [Related]
19. The significance of fibrinogen derivatives in plasma in human renal failure.
Lane DA; Ireland H; Knight I; Wolff S; Kyle P; Curtis JR
Br J Haematol; 1984 Feb; 56(2):251-60. PubMed ID: 6229269
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A
J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]